Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
August 12, 2025
Telemedicine follow-up for pre-malignant and malignant glottic lesions: a randomised controlled trial study protocol comparing care close to home versus standard of care
Nathalie F Van Rhee, Rosanne C Schoonbeek, Inge Wegner, et al.
Bone Marrow Transplantation
|
September 19, 2006
Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model
M L Grazziutti, L Dong, M H Miceli, et al.
Bone Marrow Transplantation
|
June 19, 1998
Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors
F van Rhee, D Savage, J Blackwell, et al.
Blood
|
December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
F Dazzi, R M Szydlo, C Craddock, et al.
Bone Marrow Transplantation
|
January 10, 2002
Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant
K T Godder, J Mehta, K Y Chiang, et al.
Blood
|
February 15, 1996
Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction
A Hochhaus, F Lin, A Reiter, et al.
Bone Marrow Transplantation
|
December 12, 2002
Transplantation as salvage therapy for high-risk patients with myeloma in relapse
C-K Lee, B Barlogie, M Zangari, et al.
Bone Marrow Transplantation
|
March 16, 2002
Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia
S Singhal, R Powles, P J Henslee-Downey, et al.
Leukemia
|
November 4, 2015
Clinical value of molecular subtyping multiple myeloma using gene expression profiling
N Weinhold, C J Heuck, A Rosenthal, et al.
British Journal of Haematology
|
December 12, 2001
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
T I Mughal, A Yong, R M Szydlo, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Acta Oncologica (Stockholm, Sweden)
|
August 12, 2025
Telemedicine follow-up for pre-malignant and malignant glottic lesions: a randomised controlled trial study protocol comparing care close to home versus standard of care
Nathalie F Van Rhee, Rosanne C Schoonbeek, Inge Wegner, et al.
Bone Marrow Transplantation
|
September 19, 2006
Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model
M L Grazziutti, L Dong, M H Miceli, et al.
Bone Marrow Transplantation
|
June 19, 1998
Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors
F van Rhee, D Savage, J Blackwell, et al.
Blood
|
December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
F Dazzi, R M Szydlo, C Craddock, et al.
Bone Marrow Transplantation
|
January 10, 2002
Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant
K T Godder, J Mehta, K Y Chiang, et al.
Blood
|
February 15, 1996
Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction
A Hochhaus, F Lin, A Reiter, et al.
Bone Marrow Transplantation
|
December 12, 2002
Transplantation as salvage therapy for high-risk patients with myeloma in relapse
C-K Lee, B Barlogie, M Zangari, et al.
Bone Marrow Transplantation
|
March 16, 2002
Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia
S Singhal, R Powles, P J Henslee-Downey, et al.
Leukemia
|
November 4, 2015
Clinical value of molecular subtyping multiple myeloma using gene expression profiling
N Weinhold, C J Heuck, A Rosenthal, et al.
British Journal of Haematology
|
December 12, 2001
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
T I Mughal, A Yong, R M Szydlo, et al.
Page
of 9